SNN Stock Analysis: Buy, Sell, or Hold?
SNN - Smith & Nephew plc
$32.15
0.59 (1.87%)
▲
5d:
+3.31%
30d:
+6.28%
90d:
+3.18%
HOLD
MODERATE Confidence
Analysis Updated: Jul 31, 2026 12:00 AM ET
Earnings: Aug 04, 2026
TODAY
Get Alerted When SNN Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 HOLD: SNN shows mixed signals. Fine to hold existing positions. Not urgent to buy or sell.
📊 HOLD: SNN shows mixed signals. Fine to hold existing positions. Not urgent to buy or sell.
Long-Term Wealth Forecast (2031)
Based on Analyst Consensus Growth & Historical Valuation
0% (Stagnation)
50% (Hyper Growth)
EST. PRICE IN 2031
$52.40
Based on 7.6% avg growth
INTRINSIC VALUE TODAY
$32.53
1.2% Margin of Safety
How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 15.9x Exit PE.
In-depth Analysis How we analyze
Valuation Analysis: SNN is currently trading at $32.15, which is considered extended relative to its 30-day fair value range of $29.68 to $31.62. From a valuation perspective, the stock is trading at a discount (Forward PE: 13.8) compared to its historical average (15.9). Remarkably, the market is currently pricing in an annual earnings decline of 4.6% over the next few years. This pessimistic expectation contrasts with the company's recent 70.4% earnings growth, suggesting potential undervaluation if the company simply maintains stability.
Technical Outlook: Technically, SNN is in a downtrend. The price is approaching resistance at $32.91. A breakout above this level would be a bullish signal, while rejection here could lead to consolidation.
Market Sentiment: SNN has a strong technical setup (75/100), with favorable trendlines, momentum, and price action for short-term traders. The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Technical Outlook: Technically, SNN is in a downtrend. The price is approaching resistance at $32.91. A breakout above this level would be a bullish signal, while rejection here could lead to consolidation.
Market Sentiment: SNN has a strong technical setup (75/100), with favorable trendlines, momentum, and price action for short-term traders. The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Quick Decision Summary
Current Position
EXTENDED
Historical Trading Range
$29.68 -
$31.62
Company Quality Score
51/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
57.1%
All Signals
- BEARISH: Price extended above range
- BULLISH: Strong technical setup (75/100)
- BULLISH: High volume confirmation
- NEUTRAL: Near Wall St target ($33.96)
Trading Range Analysis
30-Day Trading Range
$29.68 -
$31.62
Current vs Trading Range
EXTENDED
Support & Resistance Levels
Support Level
$29.54
Resistance Level
$32.92
Current Trend
Downtrend
Technical data as of
Aug 3, 2026
Fundamental Context
Forward P/E (Next Year Est.)
13.83
Wall Street Target
$33.96
(+7.6%)
Revenue Growth (YoY)
7.4%
Earnings Growth (YoY)
70.4%
Profit Margin
10.1%
Valuation Discount vs History
-4.6% cheaper
PE vs Historical
13.8 vs 15.9
CHEAP
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
-4.6%
(market-implied from PE analysis)
1-Year Target
$30.11
(-5%)
2-Year Target
$28.72
(-9%)
3-Year Target
$27.40
(-13%)
3-Yr Target (if PE normalizes)
(PE: 14→16)
$31.51
(0%)
3-Year Scenarios
Using analyst projected EPS growth
Bull:
(PE: 20.7, Growth: 11.3%)
$65.30
(+107%)
Base:
(SPY PE: 13.8, Growth: 11.3%)
$43.55
(+38%)
Bear:
(PE: 11.8, Growth: 11.3%)
$37.02
(+17%)
📈
Valuation based on Current Earnings
RECOVERY PLAY: Stock looks expensive now (23x PE), but valuation improves significantly next year (14x PE) as earnings recover.
Trailing PE: 22.77 | Current EPS (TTM): $1.42
Bull Case
$57.17
(+81%)
Analyst growth 60.8%, PE expands to 25.0
Base Case
$51.97
(+65%)
Market implied 60.8%, PE stable at 22.8
Bear Case
$21.98
(-30%)
Severe decline -20.0%, PE contracts to 19.4
These are projections based on PE multiples and EPS growth scenarios, not predictions. Actual results may vary significantly.
💡
Upside Surprise Potential
If earnings stabilize (0% growth), PE could expand from 13.8 to 15.9
Stabilization Target:
$36.30
(+15.0%)
PE Expansion Potential:
+15.0%
Share & Embed Analysis
Last updated: August 03, 2026 4:44 PM ET
Data refreshes hourly during market hours. Next update: 5:44 PM
Data refreshes hourly during market hours. Next update: 5:44 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is SNN showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Medical Devices Stocks
Top-rated stocks in Medical Devices by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
BSX
Boston Scientific Corp |
STRONG BUY
34 analysts |
$64 | 55 HOLD |
|
DXCM
DexCom Inc |
STRONG BUY
27 analysts |
$93 | 49 HOLD |
|
ABT
Abbott Laboratories |
STRONG BUY
27 analysts |
$118 | 52 HOLD |
|
MDT
Medtronic PLC |
BUY
32 analysts |
$98 | 57 HOLD |
|
PODD
Insulet Corporation |
STRONG BUY
24 analysts |
$236 | 51 HOLD |
